+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Analgesics Market (2021-2026) by Drug Type, Drug Class, Pain Type, Route of Administration, Distribution Channel, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis

  • PDF Icon

    Report

  • 215 Pages
  • May 2021
  • Region: Global
  • Infogence Global Research
  • ID: 5397292
The Global Analgesics Market is estimated to be USD 17.86 Bn in 2021 and is expected to reach USD 27.73 Bn by 2026, growing at a CAGR of 9.2%.



Market Dynamics

The major factor driving the growth of the global analgesics market are increased risk of heart disease, cancer, arthritis, chronic pain, and the aches and pains that the elderly population suffers from. Furthermore, advancements in treatment choices and the availability of well-established healthcare facilities are propelling the analgesics market demand. In addition, the discovery of novel medicines, growing awareness of these therapeutic alternatives, investment in research and developments by key players have supported the analgesics market and creating more opportunities for market growth.

However, uncontrolled opioid prescriptions, drug misuse, and strict regulation and policy by the government restrain the market and create challenges for the global analgesics market growth.

Market Segmentation

The Global Analgesics Market is segmented further based on Drug Type, Drug Class, Pain Type, Route of Administration, Distribution Channel, Application, and Geography.

By Drug Type, the market is classified into prescription, and over the counter (OTC), and others. Amongst all, the prescription segment is estimated to hold the highest market share during the forecast period.

By Drug Class, the market is classified as opioids, NSAID, and others. Amongst all, the Opioids segment is estimated to hold the highest market share during the forecast period.

By Pain Type, the market is classified as musculoskeletal, surgical and trauma, cancer, neuropathic, migraine, dental/facial, and others. Amongst all, the musculoskeletal segment is estimated to hold the highest market share during the forecast period.

By Route of Administration, the market is classified as oral, intravenous, rectal, transdermal, and topical. Amongst all, the oral segment is estimated to hold the highest market share during the forecast period.

By Distribution Channel, the market is classified as hospital pharmacies, retail pharmacies, drug stores. Amongst all, the hospital pharmacies segment is estimated to hold the highest market share during the forecast period.

By Application, the market is classified as internal analgesics and external analgesics. Amongst all, the internal analgesics segment is estimated to hold the highest market share during the forecast period.

By Geography, North America is projected to lead the market.

Recent Developments

1. Hikma Pharmaceuticals PLC announced a non-binding term sheet with GlaxoSmithKline PLC (GSK) to potentially acquire GSK’s pharmaceutical and consumer businesses in Egypt and its pharmaceutical business in Tunisia. - 26th January 2021
2. Pacira to Acquire Myoscience, adding Fda-Approved Iovera System for Non-Opioid Pain Control. - 5th March 2019

Company Profiles

Some of the companies covered in this report are 7T Pharma LLC, Abbott Laboratories, AbbVie Inc, Amphastar Pharmaceuticals, Inc, Aspen Pharmacare Holdings Limited, AstraZeneca PLC etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Analgesics Market . The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst’s positioning tool.

Report Highlights:
  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Analgesics Market

What is the estimated value of the Global Analgesics Market?

The Global Analgesics Market was estimated to be valued at $17860 Million in 2021.

What is the growth rate of the Global Analgesics Market?

The growth rate of the Global Analgesics Market is 9.2%, with an estimated value of $27730 Million by 2026.

What is the forecasted size of the Global Analgesics Market?

The Global Analgesics Market is estimated to be worth $27730 Million by 2026.

Who are the key companies in the Global Analgesics Market?

Key companies in the Global Analgesics Market include 7T Pharma LLC, Abbott Laboratories, AbbVie Inc, Amphastar Pharmaceuticals, Inc, Aspen Pharmacare Holdings Limited, Astrazeneca PLC, Avir Pharma Inc, B. Braun Melsungen AG and Boehringer Ingelheim International GmbH.

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size and Segmentation
3.3 Market Outlook
4 Market Influencers
4.1 Drivers
4.1.1 Increasing Geriatric Population
4.1.2 Increase Cases of Cardiovascular Disease, Cancer and Arthritis
4.1.3 Government Initiatives in Healthcare Sector
4.2 Restraints
4.2.1 Illegal Use of Opioids
4.3 Opportunities
4.3.1 Rising Investment in Research & Development
4.3.2 Growing Healthcare Sectors in Developing Countries
4.4 Challenges
4.4.1 Side Effects of Analgesics Drug
4.5 Trends
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Analgesics Market, By Drug Type
6.1 Introduction
6.2 Prescription
6.3 Over the counter (OTC)
6.4 Others
7 Global Analgesics Market, By Drug Class
7.1 Introduction
7.2 Opioids
7.3 NSAID
7.4 Others
8 Global Analgesics Market, By Pain Type
8.1 Introduction
8.2 Musculoskeletal
8.3 Surgical and Trauma
8.4 Cancer
8.5 Neuropathic
8.6 Migraine
8.7 Dental/Facial
8.8 Others
9 Global Analgesics Market, By Route of Administration
9.1 Introduction
9.2 Oral
9.3 Intravenous
9.4 Rectal
9.5 Transdermal
9.6 Topical
10 Global Analgesics Market, By Distribution Channel
10.1 Introduction
10.2 Hospital Pharmacies
10.3 Retail Pharmacies
10.4 Drug Stores
11 Global Analgesics Market, By Application
11.1 Introduction
11.2 Internal Analgesics
11.3 External Analgesics
12 Global Analgesics Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 South America
12.3.1 Brazil
12.3.2 Argentina
12.3.3 Chile
12.3.4 Colombia
12.4 Europe
12.4.1 UK
12.4.2 France
12.4.3 Germany
12.4.4 Italy
12.4.5 Spain
12.4.6 Netherlands
12.4.7 Sweden
12.4.8 Russia
12.4.9 Rest of Europe
12.5 Asia-Pacific
12.5.1 China
12.5.2 Japan
12.5.3 India
12.5.4 Indonesia
12.5.5 Malaysia
12.5.6 South Korea
12.5.7 Australia
12.5.8 Sri Lanka
12.5.9 Thailand
12.5.10 Rest of APAC
12.6 Middle-East and Africa
12.6.1 Qatar
12.6.2 Saudi Arabia
12.6.3 South Africa
12.6.4 United Arab Emirates
13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements
14 Company Profiles
14.1 7T Pharma LLC
14.2 Abbott Laboratories
14.3 AbbVie Inc
14.4 Amphastar Pharmaceuticals, Inc
14.5 Aspen Pharmacare Holdings Limited
14.6 Astrazeneca PLC
14.7 Avir Pharma Inc
14.8 B. Braun Melsungen AG
14.9 Baxter International Inc
14.10 Boehringer Ingelheim International GmbH
14.11 Braun Melsungen AG
14.12 Cantrell Drug Company
14.13 Cipher Pharmaceuticals Inc
14.14 Cipla USA Inc
14.15 Claris Life sciences
14.16 Eisai Co. Ltd
14.17 Exelan Pharmaceuticals, Inc
14.18 F. Hoffmann-La Roche Ltd
14.19 Fresenius Kabi USA, LLC
14.20 Glenmark Pharmaceuticals Limited
14.21 Hikma Pharmaceuticals PLC
14.22 Hospira, Inc
14.23 Leucadia Pharmaceuticals
14.24 Maruishi Pharmaceutical Co., Ltd.
14.25 Mylan Institutional LLC
14.26 Pacira Pharmaceuticals, Inc
14.27 Paion UK Ltd
14.28 Pfizer Inc
14.29 Piramal Enterprises LTD
14.30 Remedy Repack
15 Appendix
15.1 Questionnaire

Companies Mentioned

  • 7T Pharma LLC
  • Abbott Laboratories
  • AbbVie Inc
  • Amphastar Pharmaceuticals, Inc
  • Aspen Pharmacare Holdings Limited
  • Astrazeneca PLC
  • Avir Pharma Inc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Boehringer Ingelheim International GmbH
  • Braun Melsungen AG
  • Cantrell Drug Company
  • Cipher Pharmaceuticals Inc
  • Cipla USA Inc
  • Claris Life sciences
  • Eisai Co. Ltd
  • Exelan Pharmaceuticals, Inc
  • F. Hoffmann-La Roche Ltd
  • Fresenius Kabi USA, LLC
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals PLC
  • Hospira, Inc
  • Leucadia Pharmaceuticals
  • Maruishi Pharmaceutical Co., Ltd.
  • Mylan Institutional LLC
  • Pacira Pharmaceuticals, Inc
  • Paion UK Ltd
  • Pfizer Inc
  • Piramal Enterprises LTD
  • Remedy Repack